366 related articles for article (PubMed ID: 36523600)
1. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
[TBL] [Abstract][Full Text] [Related]
2. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
[TBL] [Abstract][Full Text] [Related]
3. Identification and Analysis of Potential Autophagy-Related Biomarkers in Endometriosis by WGCNA.
Wang J; Cong S; Wu H; He Y; Liu X; Sun L; Zhao X; Zhang G
Front Mol Biosci; 2021; 8():743012. PubMed ID: 34790699
[No Abstract] [Full Text] [Related]
4. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
Chen H; Cheng S; Xiong W; Tan X
Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
[TBL] [Abstract][Full Text] [Related]
5. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Ling KH; Abdul Hamid H
Iran J Pharm Res; 2023; 22(1):e139985. PubMed ID: 38444712
[TBL] [Abstract][Full Text] [Related]
6. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
[TBL] [Abstract][Full Text] [Related]
7. Novel Hub genes co-expression network mediates dysfunction in a model of polycystic ovary syndrome.
Xi S; Li W; Li Z; Lin W; Chen L; Tian C; Yang Y; Ma L
Am J Transl Res; 2022; 14(3):1979-1990. PubMed ID: 35422941
[TBL] [Abstract][Full Text] [Related]
8. WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.
Li M; Zeng Z; Zhang A; Ye Q; Su S; Xia T
Int J Gen Med; 2021; 14():8737-8751. PubMed ID: 34849014
[TBL] [Abstract][Full Text] [Related]
9. Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks.
Zhou W; Zhang T; Lian Y; Zhang W; Yang M; Li Y; Wang L; Yan X
Reprod Biomed Online; 2022 May; 44(5):777-790. PubMed ID: 35337736
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome.
Li Y; Tan Y
Comput Math Methods Med; 2021; 2021():9988347. PubMed ID: 34211581
[TBL] [Abstract][Full Text] [Related]
11. Identification of Inflammation-Related Genes and Exploration of Regulatory Mechanisms in Patients with Osteonecrosis of the Femoral Head.
Li T; Huang C; Ma J; Ding R; Zhang Q; Wang W
Biomed Res Int; 2022; 2022():4501186. PubMed ID: 36193326
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China.
Li Q; Sang Y; Chen Q; Ye B; Zhou X; Zhu Y
J Ovarian Res; 2023 Aug; 16(1):154. PubMed ID: 37537636
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
Qiao G; Xing J; Luo X; Zhang C; Yi J
Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
[TBL] [Abstract][Full Text] [Related]
14. Immune dysfunction mediated by the competitive endogenous RNA network in fetal side placental tissue of polycystic ovary syndrome.
Xie N; Wang F; Chen D; Zhou J; Xu J; Qu F
PLoS One; 2024; 19(3):e0300461. PubMed ID: 38512862
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
16. Weighted Gene Co-Expression Network Analysis (WGCNA) Discovered Novel Long Non-Coding RNAs for Polycystic Ovary Syndrome.
Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Abdul Hamid H; Ling KH
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831054
[TBL] [Abstract][Full Text] [Related]
17. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome.
Chen Y; Ma L; Ge Z; Pan Y; Xie L
Front Mol Biosci; 2022; 9():888194. PubMed ID: 35693550
[No Abstract] [Full Text] [Related]
18. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.
Jiao J; Shi B; Wang T; Fang Y; Cao T; Zhou Y; Wang X; Li D
Hum Reprod; 2018 Sep; 33(9):1735-1748. PubMed ID: 30052945
[TBL] [Abstract][Full Text] [Related]
19. Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data.
Berenji E; Valipour Motlagh A; Fathi M; Esmaeili M; Izadi T; Rezvanian P; Zanjirband M; Safaeinejad Z; Nasr-Esfahani MH
Sci Rep; 2024 Mar; 14(1):6180. PubMed ID: 38486041
[TBL] [Abstract][Full Text] [Related]
20. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
